Lurasidone is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions) in adults and children 13 years of age and older. It is also used to treat depression in adults and children 10 years … See more Lurasidone comes as a tablet to take by mouth. It is usually taken with a meal (at least 350 calories) once a day. Take lurasidone at around … See more Lurasidone may cause other side effects. Call your doctor if you have any unusual problems while taking this medication. If you experience a serious side effect, you or your doctor may send a report to the Food and Drug … See more Lurasidone controls schizophrenia and depression in people with bipolar disorder but it does not cure these conditions. It may take several … See more Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). It is … See more WebDec 30, 2024 · Uses for lurasidone Lurasidone is used to treat symptoms of psychotic (mental) disorders, such as schizophrenia. Lurasidone should not be used to treat …
DailyMed - LURASIDONE HYDROCHLORIDE tablet, film coated
WebOct 3, 2024 · Latuda (lurasidone hydrochloride) is an atypical antipsychotic used to treat schizophrenia. What Are Side Effects of Latuda? Latuda may cause serious side effects including: new or unusual muscle movements, lightheadedness, convulsions (seizures), irregular menstrual periods, breast or vaginal changes, nipple discharge (in women), Web時,Lurasidone 的劑量應減為原劑量的一半; 反之,若Lurasidone 和中度CYP3A4 誘導劑 併用時,以CYP3A4 誘導劑進行長期治療(7 天或更長) 後,可能需增加 Lurasidone 的劑 量。 八、懷孕與授乳 目前Lurasidone 尚無適當並控制良好於 孕婦進行的人體試驗。新生兒若 … bond ratings scale
Relapse prevention: a cost-effectiveness analysis of brexpiprazole ...
WebFeb 17, 2024 · Lurasidone is a benzoisothiazol-derivative atypical antipsychotic with mixed serotonin-dopamine antagonist activity. It exhibits high affinity for D 2, 5-HT 2A, and 5-HT 7 receptors; moderate affinity for alpha 2C -adrenergic receptors; and is a partial agonist for 5-HT 1A receptors. Web時,Lurasidone 的劑量應減為原劑量的一半; 反之,若Lurasidone 和中度CYP3A4 誘導劑 併用時,以CYP3A4 誘導劑進行長期治療(7 天或更長) 後,可能需增加 Lurasidone 的 … bond ratings s\u0026p